SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-003096
Filing Date
2023-02-17
Accepted
2023-02-16 18:06:22
Documents
111
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rare-20221231.htm   iXBRL 10-K 5395266
2 EX-10.25 rare-ex10_25.htm EX-10 562116
3 EX-10.92 rare-ex10_92.htm EX-10 44514
4 EX-10.95 rare-ex10_95.htm EX-10 1051128
5 EX-21.1 rare-ex21_1.htm EX-21 26250
6 EX-23.1 rare-ex23_1.htm EX-23 7152
7 EX-31.1 rare-ex31_1.htm EX-31 19713
8 EX-32.1 rare-ex32_1.htm EX-32 10845
9 GRAPHIC img215030536_0.jpg GRAPHIC 170282
10 GRAPHIC img215030536_1.jpg GRAPHIC 41414
  Complete submission text file 0000950170-23-003096.txt   22020040

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20221231_lab.xml EX-101.LAB 812515
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rare-20221231_def.xml EX-101.DEF 382230
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rare-20221231_cal.xml EX-101.CAL 97339
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20221231_pre.xml EX-101.PRE 642320
15 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20221231.xsd EX-101.SCH 116793
105 EXTRACTED XBRL INSTANCE DOCUMENT rare-20221231_htm.xml XML 4410950
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36276 | Film No.: 23639697
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences